Botulinum Toxin in Neurogenic Detrusor Overactivity

Purpose To evaluate the effects of botulinum toxin on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity. Methods Thirty four adult patients with spinal cord injury and detrusor overactivity were selected. The patients received 300 units of botulinum toxin ty...

Full description

Bibliographic Details
Main Authors: Carlos Arturo Levi D'Ancona, Rúiter Silva Ferreira, Mauricio Carneiro Rassi
Format: Article
Language:English
Published: Korean Continence Society 2012-09-01
Series:International Neurourology Journal
Subjects:
Online Access:http://www.einj.org/upload/pdf/inj-16-3-139-8.pdf
id doaj-012bc180a04840889d7679841ec8e106
record_format Article
spelling doaj-012bc180a04840889d7679841ec8e1062020-11-24T22:31:13ZengKorean Continence SocietyInternational Neurourology Journal2093-47772093-69312012-09-0116313914310.5213/inj.2012.16.3.13984Botulinum Toxin in Neurogenic Detrusor OveractivityCarlos Arturo Levi D'Ancona0Rúiter Silva Ferreira1Mauricio Carneiro Rassi2Division of Urology, University of Campinas School of Medicine, Campinas, Sao Paulo, Brazil.Division of Urology, University of Campinas School of Medicine, Campinas, Sao Paulo, Brazil.Division of Urology, University of Campinas School of Medicine, Campinas, Sao Paulo, Brazil.Purpose To evaluate the effects of botulinum toxin on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity. Methods Thirty four adult patients with spinal cord injury and detrusor overactivity were selected. The patients received 300 units of botulinum toxin type A. The endpoints evaluated with the episodes of urinary incontinence and measured the maximum cystometric capacity, maximum amplitude of detrusor pressure and bladder compliance at the beginning and end of the study (24 weeks) and evaluated the quality of life by applying the Qualiveen questionnaire. Results A significant decrease in the episodes of urinary incontinence was observed. All urodynamic parameters presented a significant improvement. The same was observed in the quality of life index and the specific impact of urinary problems scores from the Qualiveen questionnaire. Six patients did not complete the study, two due to incomplete follow-up, and four violated protocol and were excluded from the analyses. No systemic adverse events of botulinum toxin type A were reported. Conclusions A botulinum toxin type A showed a significantly improved response in urodynamics parameters and specific and general quality of life.http://www.einj.org/upload/pdf/inj-16-3-139-8.pdfOveractive urinary bladderBotulinum toxinsQuality of lifeUrodynamics
collection DOAJ
language English
format Article
sources DOAJ
author Carlos Arturo Levi D'Ancona
Rúiter Silva Ferreira
Mauricio Carneiro Rassi
spellingShingle Carlos Arturo Levi D'Ancona
Rúiter Silva Ferreira
Mauricio Carneiro Rassi
Botulinum Toxin in Neurogenic Detrusor Overactivity
International Neurourology Journal
Overactive urinary bladder
Botulinum toxins
Quality of life
Urodynamics
author_facet Carlos Arturo Levi D'Ancona
Rúiter Silva Ferreira
Mauricio Carneiro Rassi
author_sort Carlos Arturo Levi D'Ancona
title Botulinum Toxin in Neurogenic Detrusor Overactivity
title_short Botulinum Toxin in Neurogenic Detrusor Overactivity
title_full Botulinum Toxin in Neurogenic Detrusor Overactivity
title_fullStr Botulinum Toxin in Neurogenic Detrusor Overactivity
title_full_unstemmed Botulinum Toxin in Neurogenic Detrusor Overactivity
title_sort botulinum toxin in neurogenic detrusor overactivity
publisher Korean Continence Society
series International Neurourology Journal
issn 2093-4777
2093-6931
publishDate 2012-09-01
description Purpose To evaluate the effects of botulinum toxin on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity. Methods Thirty four adult patients with spinal cord injury and detrusor overactivity were selected. The patients received 300 units of botulinum toxin type A. The endpoints evaluated with the episodes of urinary incontinence and measured the maximum cystometric capacity, maximum amplitude of detrusor pressure and bladder compliance at the beginning and end of the study (24 weeks) and evaluated the quality of life by applying the Qualiveen questionnaire. Results A significant decrease in the episodes of urinary incontinence was observed. All urodynamic parameters presented a significant improvement. The same was observed in the quality of life index and the specific impact of urinary problems scores from the Qualiveen questionnaire. Six patients did not complete the study, two due to incomplete follow-up, and four violated protocol and were excluded from the analyses. No systemic adverse events of botulinum toxin type A were reported. Conclusions A botulinum toxin type A showed a significantly improved response in urodynamics parameters and specific and general quality of life.
topic Overactive urinary bladder
Botulinum toxins
Quality of life
Urodynamics
url http://www.einj.org/upload/pdf/inj-16-3-139-8.pdf
work_keys_str_mv AT carlosarturolevidancona botulinumtoxininneurogenicdetrusoroveractivity
AT ruitersilvaferreira botulinumtoxininneurogenicdetrusoroveractivity
AT mauriciocarneirorassi botulinumtoxininneurogenicdetrusoroveractivity
_version_ 1725738179358621696